B C Boer1,2, F de Graaff1,3, M Brusse-Keizer4, D E Bouman5, C H Slump3, M Slee-Valentijn6, J M Klaase7. 1. Department of Surgery, Medisch Spectrum Twente, Enschede, Netherlands. 2. Faculty of Medical Sciences, University of Groningen, Groningen, Netherlands. 3. Faculty of Science and Technology, University of Twente, Enschede, Netherlands. 4. Medical School Twente, Medisch Spectrum Twente, Enschede, Netherlands. 5. Department of Radiology, Medisch Spectrum Twente, Enschede, Netherlands. 6. Department of Internal Medicine-Section of Gerontology and Geriatrics, VU University Medical Center, Amsterdam, Netherlands. 7. Department of Surgery, Medisch Spectrum Twente, Enschede, Netherlands. j.klaase@mst.nl.
Abstract
BACKGROUND: The prevalence of colorectal cancer in the elderly is increasing and, therefore, surgical interventions with a risk of potential complications are more frequently performed. This study investigated the role of low skeletal muscle mass (sarcopenia), muscle quality, and the sarcopenic obesity as prognostic factors for postoperative complications and survival in patients with resectable colon cancer. METHODS: We conducted a retrospective chart review of 91 consecutive patients who underwent an elective open colon resection for cancer with primary anastomosis between 2011 and 2013. Skeletal muscle mass was measured as total psoas area (TPA) and total abdominal muscle area (TAMA) at three anatomical levels on the preoperative CT scan. Skeletal muscle quality was measured using corresponding mean Hounsfield units (HU) for TAMA. Their relation with complications (none vs one or more), severe complications, and survival was analyzed. RESULTS: The study included 91 patients with a mean age of 71.2 ± 9.7 years. Complications were noted in 55 patients (60 %), of which 15 (16.4 %) were severe. Lower HU for TAMA, as an indicator for impaired skeletal muscle quality, was an independent risk factor for one or more complications (all P ≤ 0.002), while sarcopenic obesity (TPA) was an independent risk factor for severe complications (all P ≤ 0.008). Sarcopenia was an independent predictor of worse overall survival (HR 8.54; 95 % confidence interval (CI) 1.07-68.32). CONCLUSION: Skeletal muscle quality is a predictor for overall complications, whereas sarcopenic obesity is a predictor for severe postoperative complications after open colon resection for cancer. Sarcopenia on itself is a predictor for worse overall survival.
BACKGROUND: The prevalence of colorectal cancer in the elderly is increasing and, therefore, surgical interventions with a risk of potential complications are more frequently performed. This study investigated the role of low skeletal muscle mass (sarcopenia), muscle quality, and the sarcopenic obesity as prognostic factors for postoperative complications and survival in patients with resectable colon cancer. METHODS: We conducted a retrospective chart review of 91 consecutive patients who underwent an elective open colon resection for cancer with primary anastomosis between 2011 and 2013. Skeletal muscle mass was measured as total psoas area (TPA) and total abdominal muscle area (TAMA) at three anatomical levels on the preoperative CT scan. Skeletal muscle quality was measured using corresponding mean Hounsfield units (HU) for TAMA. Their relation with complications (none vs one or more), severe complications, and survival was analyzed. RESULTS: The study included 91 patients with a mean age of 71.2 ± 9.7 years. Complications were noted in 55 patients (60 %), of which 15 (16.4 %) were severe. Lower HU for TAMA, as an indicator for impaired skeletal muscle quality, was an independent risk factor for one or more complications (all P ≤ 0.002), while sarcopenic obesity (TPA) was an independent risk factor for severe complications (all P ≤ 0.008). Sarcopenia was an independent predictor of worse overall survival (HR 8.54; 95 % confidence interval (CI) 1.07-68.32). CONCLUSION: Skeletal muscle quality is a predictor for overall complications, whereas sarcopenic obesity is a predictor for severe postoperative complications after open colon resection for cancer. Sarcopenia on itself is a predictor for worse overall survival.
Authors: A Y Bijlsma; C G M Meskers; N van den Eshof; R G Westendorp; S Sipilä; L Stenroth; E Sillanpää; J S McPhee; D A Jones; M V Narici; H Gapeyeva; M Pääsuke; T Voit; Y Barnouin; J Y Hogrel; G Butler-Browne; A B Maier Journal: Age (Dordr) Date: 2013-07-02
Authors: Jay Soong-Jin Lee; Kevin He; Calista M Harbaugh; Douglas E Schaubel; Christopher J Sonnenday; Stewart C Wang; Michael J Englesbe; Jonathan L Eliason Journal: J Vasc Surg Date: 2011-01-07 Impact factor: 4.268
Authors: Courtney J Balentine; Christy Marshall; Celia Robinson; Jonathan Wilks; Daniel Anaya; Daniel Albo; David H Berger Journal: J Surg Res Date: 2010-06-13 Impact factor: 2.192
Authors: Peter Peng; Omar Hyder; Amin Firoozmand; Peter Kneuertz; Richard D Schulick; Donghang Huang; Martin Makary; Kenzo Hirose; Barish Edil; Michael A Choti; Joseph Herman; John L Cameron; Christopher L Wolfgang; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2012-06-13 Impact factor: 3.452
Authors: Michael J Englesbe; Jay S Lee; Kevin He; Ludi Fan; Douglas E Schaubel; Kyle H Sheetz; Calista M Harbaugh; Sven A Holcombe; Darrel A Campbell; Christopher J Sonnenday; Stewart C Wang Journal: Ann Surg Date: 2012-08 Impact factor: 12.969
Authors: Candyce H Kroenke; Carla M Prado; Jeffrey A Meyerhardt; Erin K Weltzien; Jingjie Xiao; Elizabeth M Cespedes Feliciano; Bette J Caan Journal: Cancer Date: 2018-05-24 Impact factor: 6.860
Authors: Bette J Caan; Jeffrey A Meyerhardt; Candyce H Kroenke; Stacey Alexeeff; Jingjie Xiao; Erin Weltzien; Elizabeth Cespedes Feliciano; Adrienne L Castillo; Charles P Quesenberry; Marilyn L Kwan; Carla M Prado Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-05-15 Impact factor: 4.254
Authors: Paul E Wischmeyer; Zudin Puthucheary; Iñigo San Millán; Daniel Butz; Michael P W Grocott Journal: Curr Opin Crit Care Date: 2017-08 Impact factor: 3.687
Authors: Stéphanie M L M Looijaard; Carel G M Meskers; Monique S Slee-Valentijn; Donald E Bouman; A N Machteld Wymenga; Joost M Klaase; Andrea B Maier Journal: Oncologist Date: 2019-11-20